Bioanalytics
Providing vast bioanalytics expertise for innovative medicines and next-generation biologics, as well as cell and gene therapy.
Resolian’s global Bioanalytics division has an extensive track record across therapeutic modalities and biological matrices, including conventional small molecules, peptides, biologics, antibody drug conjugates (ADCs), and oligonucleotides.
Reach out to us directly to learn more about Resolian’s Bioanalytics services.
Our Bioanalytical Services
Technologies
Immunoassay
Ligand binding assays developed, validated, and implemented to GxP across wide-ranging therapeutic modalities.
High Resolution Mass Spectrometry (HR-MS)
Offering experience with state-of-the-art HR-MS technology.
Flow Cytometry
Offering a range of assays to support drug development, from pre-clinical to late-phase.
Therapeutics and Testing
Peptide Analysis
Experts in offering you bioanalytical solutions using LC-MS/MS technology.
Protein and Oligonucleotide LC-MS
Offering specialized Protein and Oligonucleotide LC-MS services.
Drug Metabolism and Pharmacokinetics
Supporting early drug discovery and late-stage drug development with state-of-the-art technologies.
Cell and Gene Therapy
Comprehensive, purpose-built CGT services (including PCR, Flow Cytometry, ELISpot, ADA/nAb, and Biomarkers) to support your research.
Immunogenicity
Developing, validating and implementing anti-drug antibody (ADA) immunogenicity and neutralizing antibody (nAb) assays.
Clinical Drug-Drug Interaction (DDI) Studies
Supporting in vivo DDI studies in clinical drug development through quantitative LC-MS/MS assays.
Bioanalysis of Cannabinoids
An LC-MS team specializing in tailored assays for precise cannabinoid PK measurements.
